Switch to
Predicate | Object |
---|---|
rdf:type | |
pubmed:issue |
2
|
pubmed:dateCreated |
1998-4-6
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0002-9297
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
492-5
|
pubmed:dateRevised |
2008-11-20
|
pubmed:meshHeading |
pubmed-meshheading:9463338-Cytochrome b Group,
pubmed-meshheading:9463338-DNA, Mitochondrial,
pubmed-meshheading:9463338-Female,
pubmed-meshheading:9463338-Genomic Imprinting,
pubmed-meshheading:9463338-Humans,
pubmed-meshheading:9463338-Male,
pubmed-meshheading:9463338-Optic Atrophies, Hereditary,
pubmed-meshheading:9463338-Pedigree,
pubmed-meshheading:9463338-Point Mutation
|
pubmed:year |
1998
|
pubmed:articleTitle |
Reply to Hofmann et al.
|
pubmed:publicationType |
Letter
|